MRVL vs RTX: Which Is the Better Buy?

Side-by-side comparison of Marvell Technology, Inc. and RTX Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-04.
Marvell Technology, Inc. Β· Technology
$133.37
+25.2% upside to fair value
High Conviction Grade B
VS
RTX Corporation Β· Industrials
$172.90
-21.3% upside to fair value
Grade D
QuantHub Verdict
MRVL has more upside to fair value (+25.2%). RTX trades at a lower forward P/E (32.1x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MRVL RTX
Current Price $133.37 $172.90
Fair Value Estimate $167.00 $136.05
Upside to Fair Value +25.2% -21.3%
Market Cap $116.6B $232.8B
Forward P/E 42.4x 32.1x
EV / EBITDA β€” 19.2x
Price / Sales 14.2x 2.6x
Price / FCF 83.7x 27.9x
Revenue Growth YoY +7.0% +8.7%
Gross Margin 50.1% 20.2%
Operating Margin 16.3% 10.4%
Return on Equity 19.4% 11.2%
Dividend Yield β€” 0%
FCF Yield 1.2% 3.59%
Analyst Consensus Strong Buy Buy
Investment Thesis
MRVL β€” Marvell Technology, Inc.
Marvell Technology designs semiconductors for data infrastructure, including storage, networking, connectivity for AI, cloud, 5G, and automotive; the business excels with a dominant Data Center segment driving 42% FY2026 revenue growth to $8.2B amid AI demand, strong leadership under long-tenured CEO Matt Murphy, and robust 50% gross margins, though offset by earnings decline and non-Data Center …
RTX β€” RTX Corporation
RTX Corporation is a leading aerospace and defense company with a diversified portfolio spanning Pratt & Whitney jet engines, Collins Aerospace avionics, and Raytheon Intelligence & Space defense systems. The company benefits from a strong competitive moat supported by a $271 billion backlog and multi-year contracts, driving consistent revenue growth of 10% in 2025 and 9% in Q1 2026. Earnings gro…
Accumulation Zones
Metric MRVL RTX
Zone Low $125.00 $102.04
Zone High $142.00 $115.64
In Buy Zone? Yes No
← MRVL Research    RTX Research β†’    All Research